445 related articles for article (PubMed ID: 10695405)
1. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
Harigai M; Hara M; Kamatani N; Kashiwazaki S
Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
3. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.
Kotani T; Makino S; Takeuchi T; Kagitani M; Shoda T; Hata A; Tabushi Y; Hanafusa T
J Rheumatol; 2008 Feb; 35(2):254-9. PubMed ID: 18085732
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
[TBL] [Abstract][Full Text] [Related]
5. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
[TBL] [Abstract][Full Text] [Related]
6. [Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM)].
Saeki T; Suzuki E; Watanabe T; Saito Y; Itou S; Honma T; Sato T; Nakano M; Arakawa M
Ryumachi; 1994 Feb; 34(1):16-21. PubMed ID: 8146722
[TBL] [Abstract][Full Text] [Related]
7. [Cyclosporin A treatment of interstitial pneumonia].
Homma S; Kawabata M; Kishi K; Tsuboi E; Narui K; Nakatani T; Matsushita H; Kurosaki A; Nakata K
Nihon Kokyuki Gakkai Zasshi; 2003 Jul; 41(7):427-33. PubMed ID: 12931668
[TBL] [Abstract][Full Text] [Related]
8. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
Takada K; Nagasaka K; Miyasaka N
Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.
Qushmaq KA; Chalmers A; Esdaile JM
J Rheumatol; 2000 Dec; 27(12):2855-9. PubMed ID: 11128676
[TBL] [Abstract][Full Text] [Related]
10. Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis.
Yamanaka Y; Baba T; Hagiwara E; Yanagawa N; Takemura T; Nagaoka S; Sakai F; Kuwano K; Ogura T
Eur J Radiol; 2018 Oct; 107():26-32. PubMed ID: 30292269
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary involvements in patients with collagen disease].
Endo H
Nihon Rinsho; 2009 Mar; 67(3):536-41. PubMed ID: 19280929
[TBL] [Abstract][Full Text] [Related]
12. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
13. Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
Fujita J; Dobashi N; Tokuda M; Bandoh S; Ohtsuki Y; Yamadori I; Yoshinouchi T; Ueda Y; Takahara J
J Rheumatol; 1999 Nov; 26(11):2377-82. PubMed ID: 10555895
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic efficacy of cyclosporin A in four cases of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia].
Ozawa Y; Kurosaka D; Yokoyama T; Tajima N
Ryumachi; 2000 Oct; 40(5):798-809. PubMed ID: 11215158
[TBL] [Abstract][Full Text] [Related]
15. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.
Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X
Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970
[TBL] [Abstract][Full Text] [Related]
16. Large macrophage colony-forming cells identical to high proliferative potential colony-forming cells in peripheral blood of patients with collagen vascular diseases: high occurrence among patients with systemic sclerosis and dermatomyositis.
Horie S; Minota S; Kano S
J Rheumatol; 2000 Oct; 27(10):2378-81. PubMed ID: 11036833
[TBL] [Abstract][Full Text] [Related]
17. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis?
Tunc SE; Ertam I; Pirildar T; Turk T; Ozturk M; Doganavsargil E
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):497-503. PubMed ID: 17373977
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of DLco for the early diagnosis of pulmonary involvement in collagen diseases].
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Apr; 31(4):480-5. PubMed ID: 8515621
[TBL] [Abstract][Full Text] [Related]
19. [Interstitial pneumonia associated with collagen vascular diseases: histological findings, and cells in bronchoalveolar lavage fluid].
Nagai S; Satake N; Kitaichi M; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():258-63. PubMed ID: 8752516
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis].
Saku N; Ohno S; Sugiyama Y; Kitamura S
Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):585-9. PubMed ID: 9805908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
